Patent assignee · DE · COMPANY

ID Pharma Co., Ltd.

10Patents
9Active
10Granted
44Portfolio score

Filing activity: Feb 2, 2000 → Nov 17, 2017

Most-cited patents

PatentTitleAreaCited byStatus
US6339079B1 Steroid sulfamates, method for the production and use thereof Emerging Cross-Sectional Technologies 10 Expired
US11136594B2 Method for production of reprogrammed cell using chromosomally unintegrated virus vector Chemistry; Metallurgy 2 Active
US12252700B2 Paramyxovirus vector Chemistry; Metallurgy 0 Active
US10828359B2 Anti-Mycobacterium tuberculosis vaccine using sendai virus as vector Chemistry; Metallurgy 0 Active
US9492485B2 Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor Chemistry; Metallurgy 0 Active
US10975358B2 Method for improving efficiency of inducing pluripotent stem cell Chemistry; Metallurgy 0 Active
US10704061B2 Lentiviral vectors Chemistry; Metallurgy 0 Active
US11103574B2 Infectious disease vaccine using non-infectious paramyxovirus particle Chemistry; Metallurgy 0 Active
US9695445B2 Method for production of reprogrammed cell using chromosomally unintegrated virus vector Chemistry; Metallurgy 0 Active
US10017784B2 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.